Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Ob/Gyn Information Center

FDA Requests Removal of Pregnancy Contraindication for Statins

Brian Park, PharmD

July 22, 2021

The FDA conducted a comprehensive review of all available data associated with the use of statins during pregnancy.

Pain Management Information Center

Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents

Brian Park, PharmD

July 12, 2021

Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.

Infectious Diseases Information Center

FDA: Systemic Side Effects Reported After Hand Sanitizer Application

Brian Park, PharmD

June 18, 2021

The FDA reviewed case reports from the FAERS database and calls from US poison control centers related to systemic symptoms after applying alcohol-based hand sanitizers to the skin.

Infectious Diseases Information Center, Pediatrics Information Center

Pediatric Hexavalent Combination Vaccine Vaxelis Now Available

Brian Park, PharmD

June 11, 2021

Vaxelis is the first hexavalent combination vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.

Ob/Gyn Information Center

Brexafemme Approved for Vulvovaginal Candidasis

Brian Park, PharmD

June 4, 2021

The approval was based on data from 2phase 3 trials that compared Brexafemme to placebo in patients aged 12 years and older with acute VVC.

ADHD Information Center

FDA Clears AI-Based Diagnostic Aid for Autism Spectrum Disorder

Brian Park, PharmD

June 3, 2021

The approval was based on safety and efficacy data from a study that included 425 patients 18 months through 5 years of age.

Infectious Diseases Information Center

CDC: Fully Vaccinated Can Now Go Maskless With Some Exceptions

Brian Park, PharmD

May 13, 2021

Fully vaccinated individuals may resume indoor and outdoor activities without wearing masks or physical distancing, except under certain circumstances.

Psychiatry Information Center

Evekeo ODT Approved for Younger Patients With ADHD

Brian Park, PharmD

April 28, 2021

Evekeo ODT, a Schedule II controlled substance, contains a 1:1 racemic mixture of dextroamphetamine sulfate and levoamphetamine sulfate.

Cardiovascular Disease Information Center

Diovan Approved for Younger Patients With Hypertension

Brian Park, PharmD

April 28, 2021

The approval was based on data from 3 clinical studies that assessed the antihypertensive effect of valsartan in 290 children 1 to less than 6 years of age.

ADHD Information Center, News

Qelbree, a Nonstimulant Treatment for ADHD, Gets FDA Approval

Brian Park, PharmD

April 6, 2021

The approval was based on data from an extensive development program that included four phase 3 studies involving more than 1000 patients 6 to 17 years of age.

Next post in ADHD Information Center